Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ana Rosa Rubio-Salvador"'
Autor:
María Yébenes Cortés, Ana Rosa Rubio-Salvador, Vicente Escudero-Vilaplana, Beatriz Bernardez, Manuel Gómez Barrera, María Dolores Alvarado Fernández, José Antonio Marcos Rodríguez, Irene Mangues-Bafalluy, Roberto Collado-Borrell, José Ignacio Chacón López-Muñiz, Miguel Ángel Calleja-Hernández, Carlos García Collado
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 18, Iss 394, p 394 (2021)
International Journal of Environmental Research and Public Health
Volume 18
Issue 2
International Journal of Environmental Research and Public Health
Volume 18
Issue 2
Background: Patients with lung cancer (LC) are at significantly higher risk of developing venous thromboembolism (VTE), which may lead to increased use of health resources and the cost of management. The main aim of the study was to determine the cos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4d61a4f3a4215a8f337168a1c83ed96
https://www.mdpi.com/1660-4601/18/2/394
https://www.mdpi.com/1660-4601/18/2/394
Autor:
Juan David Cardenas, Carmen Esteban, Iciar Garcia Carbonero, Adriana Rosero, Katherin Martinez Barroso, Miguel Borregon Rivilla, Ana Rosa Rubio Salvador, Paul Martin Aguilar Angulo, Maria Garcia Avila, Jose Ignacio Chacon, Juan Ruiz Martin
Publikováno v:
Journal of Clinical Oncology. 37:e12117-e12117
e12117 Background: Triple-negative breast cancer (TNBC) remains a poor prognosis subtype of breast cancer (BC). We are lacking of definitive effective combinations in this tumor. So, it is warranted to explore new combinations. Neo-adjuvant setting i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::860db0b18bb925dfff46063b7ffe18c2
https://doi.org/10.1200/jco.2019.37.15_suppl.e12117
https://doi.org/10.1200/jco.2019.37.15_suppl.e12117
Autor:
Maria Garcia Avila, Elia Martinez, Blanca Lourdes Trujillo Alba, Raquel Sanchez-Simon, Jose Ignacio Chacon, Cristina Romero, Ana Rosa Rubio Salvador, Ana Dominguez Barahona, Carmen Esteban, Juan David Cárdenas
Publikováno v:
Journal of Clinical Oncology. 36:e12660-e12660
e12117Background: Triple-negative breast cancer (TNBC) remains a poor prognosis subtype of breast cancer (BC). We are lacking of definitive effective combinations in this tumor. So, it is warranted...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7a2351deb65fa8b358b10998620cd12
https://doi.org/10.1200/jco.2018.36.15_suppl.e12660
https://doi.org/10.1200/jco.2018.36.15_suppl.e12660
Autor:
Iciar Garcia Carbonero, Amalia Gonzalez, Maria Sanchez Garcia, Carmen Esteban, Jose Ignacio Chacon, Miguel A. Cruz, Ana Rosa Rubio Salvador, Paloma Moya Gomez, Jesus Andrade, Antonio Irigoyen, Ruth Alvarez, Luis Lopez-Gomez, Medina Javier
Publikováno v:
Journal of Clinical Oncology. 32:e17544-e17544
e17544 Background: To determine the direct economic impact attributable to drugs assigned to patients (pts) enrolled in clinical trials (CT) by the medical oncology department of a third level hosp...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5148f6f0b67ea4b42d4e82181601fe6b
https://doi.org/10.1200/jco.2014.32.15_suppl.e17544
https://doi.org/10.1200/jco.2014.32.15_suppl.e17544
Autor:
Ana Rosa Rubio Salvador, Laura Diaz Paniagua, Jose Ignacio Chacon, Miguel Angel Cruz Mora, Lourdes Fernandez Franco, Sonia Alonso Soler, Carmen Esteban, Begona Martinez Carrasco, Nazaret Cordero Franco, Paloma Moya Gomez, Alberto San Juan del Moral
Publikováno v:
Web of Science
e11543 Background: Triple negative breast cancer (TNBC) is an anthracycline resistant subtype, for which there is no standard chemotherapy. Taxanes, platinum-derived drugs and bevacizumab all seem to be active drugs in this setting, but definitive da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c10dddebabc5a744581463207d44a3
https://doi.org/10.1200/jco.2012.30.15_suppl.e11543
https://doi.org/10.1200/jco.2012.30.15_suppl.e11543
Autor:
Jose Ignacio Chacon, Carmen Esteban, Laura Diaz Paniagua, Alberto San Juan del Moral, Begona Martinez Carrasco, Miguel Angel Cruz Mora, Nazaret Cordero Franco, Sonia Alonso Soler, Enriqueta Munoz Platon, Ana Rosa Rubio Salvador, José Manuel Martínez Sesmero, Lourdes Fernandez Franco, Paloma Moya Gomez
Publikováno v:
Web of Science
e19596 Background: ZA therapy has been associated with the development of ONJ. In Nov 8th, 2005, osteonecrosis of the jaw was elevated to a safety warning by Spanish Drug Agency (SDA). The aim of this study was to investigate if that warning has had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e8165659da5b1d9febe981c3dc165c3
https://publons.com/wos-op/publon/54862455/
https://publons.com/wos-op/publon/54862455/
Autor:
Ana Rosa Rubio Salvador, Miguel Angel Mareque Ruiz, Maria Sanchez Garcia, Jose Ignacio Chacon, José Manuel Martínez Sesmero, Carmen Esteban, Miguel A. Cruz, Paloma Moya Gomez
Publikováno v:
Web of Science
e17665 Background: Medication reconciliation (MR) is a defined methodology to optimize drug therapy while reducing adverse drug events at transition points across the continuum of care. Methods: An...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86853398f7d5345a3b71b95306b1ba11
https://publons.com/wos-op/publon/54862446/
https://publons.com/wos-op/publon/54862446/